As of 2025-04-25, the Relative Valuation of Olema Pharmaceuticals Inc (OLMA) is (64.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.10 USD, the upside of Olema Pharmaceuticals Inc based on Relative Valuation is -1355.8%.
The range of the Relative Valuation is (53.13) - (83.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.0x - 44.0x | 36.8x |
| Forward P/E multiples | 24.0x - 44.9x | 30.8x |
| Fair Price | (53.13) - (83.37) | (64.05) |
| Upside | -1141.8% - -1734.8% | -1355.8% |
| Date | P/E |
| 2025-04-22 | -2.62 |
| 2025-04-21 | -2.51 |
| 2025-04-17 | -2.33 |
| 2025-04-16 | -2.25 |
| 2025-04-15 | -2.22 |
| 2025-04-14 | -2.14 |
| 2025-04-11 | -1.99 |
| 2025-04-10 | -1.80 |
| 2025-04-09 | -1.66 |
| 2025-04-08 | -1.61 |
| 2025-04-07 | -1.68 |
| 2025-04-04 | -1.72 |
| 2025-04-03 | -1.77 |
| 2025-04-02 | -1.76 |
| 2025-04-01 | -1.76 |
| 2025-03-31 | -1.98 |
| 2025-03-28 | -2.17 |
| 2025-03-27 | -2.22 |
| 2025-03-26 | -2.18 |
| 2025-03-25 | -2.21 |
| 2025-03-24 | -2.28 |
| 2025-03-21 | -2.23 |
| 2025-03-20 | -2.17 |
| 2025-03-19 | -2.17 |
| 2025-03-18 | -2.18 |
| 2025-03-17 | -2.35 |
| 2025-03-14 | -2.33 |
| 2025-03-13 | -2.31 |
| 2025-03-12 | -2.38 |
| 2025-03-11 | -2.29 |
| 2025-03-10 | -2.33 |
| 2025-03-07 | -2.43 |
| 2025-03-06 | -2.37 |
| 2025-03-05 | -2.25 |
| 2025-03-04 | -2.22 |
| 2025-03-03 | -2.22 |
| 2025-02-28 | -2.31 |
| 2025-02-27 | -2.33 |
| 2025-02-26 | -2.43 |
| 2025-02-25 | -2.46 |
| 2025-02-24 | -2.54 |
| 2025-02-21 | -2.63 |
| 2025-02-20 | -2.68 |
| 2025-02-19 | -2.72 |
| 2025-02-18 | -2.66 |
| 2025-02-14 | -2.62 |
| 2025-02-13 | -2.55 |
| 2025-02-12 | -2.61 |
| 2025-02-11 | -2.75 |
| 2025-02-10 | -2.72 |